Korawit Juprasertporn: JCM Special Issue Launches with Its 1st Article on Advances in Bleeding Disorders
Korawit Juprasertporn, Section Managing Editor at MDPI, shared on LinkedIn about a recent article by Giancarlo Castaman et al, published in JCM MDPI, adding:
”First article published in our special issue!
I am delighted to announce the publication of the first article in our Special Issue:
‘Bleeding Disorders and Hemophilia: Clinical Advances and Treatment’ – published in the Journal of Clinical Medicine (JCM) MDPI.
This Special Issue is led by Assoc. Prof. Dr. Loredana Liliana Hurjui and Assoc. Prof. Dr. Claudia Cristina Tarniceriu, and aims to showcase the latest advances in the understanding and management of bleeding disorders and hemophilia.
The publication of the first article marks an exciting milestone and sets the stage for a growing collection of high-quality research in this rapidly evolving field.
We are still welcoming submissions!
We invite researchers and clinicians working in hemophilia, inherited and acquired bleeding disorders, hemostasis, thrombosis, coagulation, gene therapy, and hematology to submit their latest original research and review articles.
Together, let’s advance clinical care and improve outcomes for patients with bleeding disorders and hemophilia.”
Title: Evolution of Hemophilia Management in Italy: Results from a Delphi Consensus Study
Authors: Giancarlo Castaman, Raimondo De Cristofaro, Matteo Nicola Dario Di Minno, Francesca Gatto, Paolo Mariani, Angelo Claudio Molinari, Mariasanta Napolitano, Cristina Santoro, Rita Carlotta Santoro, Ezio Zanon
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?
-
Sep 20, 2026, 00:58Hamza Rafiq: How Does a Deep Vein Thrombosis Become a PE?
-
Sep 20, 2026, 00:50A Shared Platelet Factor 4–Targeted Immune Mechanism in Adenovirus Infection – NEJM